Since the inception of its operation in the global market in 2018, Everest Pharma successfully made its journey achieving major milestones in different segments like launching 1st global generic version of Olaparib 50 mg Capsule with the brand name Olanib to treat ovarian cancer as the targeted therapy, manufacturing and marketing of many targeted anticancer products and antiviral products for both the local and global market. Now its anticancer and antiviral portfolios have been enriched with many latest branded generics and many more are in pipeline. In 2020, Everest Pharma successfully introduced pharma products in the local market with many 1st -Time-in Bangladesh molecules and since then its journey of success is going on in terms of physician acceptance, chemist coverage and the nation-wide strong coverage through its skilled sales, marketing & distribution network.